Clin2
NCT06964334Possibly a fitNot yet recruiting

Vitamin D for H. pylori in children

Helicobacter Pylori Infection

Treatments studied

Part of Digestive system, Infections clinical trials.

This trial tests whether adding vitamin D to standard H. pylori treatment helps clear the infection better in children. Children with H. pylori and ongoing symptoms may benefit from this extra therapy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
70 people
Ages
1 year to 18 years
Study type
Interventional

Who can take part

  • Patient must be between 1 and 16 years old.
  • H. pylori infection must be confirmed by a positive stool antigen test.
  • Symptoms such as belly pain, weight loss, or slow growth must have lasted at least one month.
  • Cannot have already received treatment for H. pylori, or used steroids or acid-blocking medicines in the past 2 months.
  • Cannot have certain serious health conditions like kidney failure, liver disease, cancer, or autoimmune disorders.
  • Cannot have a history of premature birth, asphyxia, severe genetic or metabolic disease, or severe malnutrition.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07260006Recruiting
Bismuth therapy for H. pylori ulcers in children

This trial tests whether adding bismuth to standard treatment works better for children with stomach ulcers caused by H. pylori infection. If your child has been diagnosed with an H. pylori ulcer, this study could help find the best medicine.

Can Tho
NCT05926804Recruiting
Screening and treatment for Helicobacter pylori in teens

This trial checks teenagers for a long-lasting H. pylori stomach infection and then treats those who need it. It may help prevent ongoing stomach problems from the infection and compare outcomes between treated and non-treated groups.

Coyhaique
NCT06546111Recruiting· Phase 1/Phase 2
Diosmin and hesperidin for H. pylori infection

This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.

Shibīn al Kawm
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT06200779Not yet recruiting· Phase 4
Tailored vs. standard treatment for H. pylori infection

This trial compares a personalized treatment approach to the standard one for H. pylori infection. If you are scheduled for an upper endoscopy and need biopsies, you may be able to join.

Porto, Porto District

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.